Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

<p>Abstract</p> <p>Optimal conditioning therapy for hematopoietic cell transplantation (HCT) in acute myelogenous leukemia (AML) remains undefined. We retrospectively compared outcomes of a consecutive series of 51 AML patients treated with oral busulfan (1 mg/kg every 6 hours for 4 days) and cyclop...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nishihori Taiga, Kharfan-Dabaja Mohamed A, Anasetti Claudio, Kim Jongphil, Pidala Joseph, Field Teresa, Perkins Janelle, Perez Lia, Fernandez Hugo F
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2010-10-01
Col·lecció:	Journal of Hematology & Oncology
Accés en línia:	http://www.jhoonline.org/content/3/1/36
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!